Search research articles
Contact Us
Filters
Showing results (291-300 of 305) with videos related to
Page
of 31
Sort By:
The New England Journal of Medicine
|
April 30, 2015
Rociletinib in EGFR-mutated non-small-cell lung cancer
Lecia V Sequist, Jean-Charles Soria, Jonathan W Goldman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 18, 2025
Amivantamab in Participants with Advanced Non-small Cell Lung Cancer (NSCLC) and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study
Matthew G Krebs, Byoung Chul Cho, Sandrine Hiret, et al.
Cancer
|
November 11, 2017
Non-small cell lung cancer clinical trials requiring biopsies with biomarker-specific results for enrollment provide unique challenges
Marshall L Spiegel, Jonathan W Goldman, Brian R Wolf, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 13, 2021
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Apar Kishor P Ganti, Billy W Loo, Michael Bassetti, et al.
Cancer Discovery
|
November 17, 2019
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Lawrence Fong, Andrew Hotson, John D Powderly, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2026
NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026
Apar Kishor P Ganti, Billy W Loo, Shahed Badiyan, et al.
The New England Journal of Medicine
|
March 25, 2026
Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer
Wungki Park, Anup Kasi, Alexander I Spira, et al.
Nature Medicine
|
March 28, 2024
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
Amy R Rappaport, Chrisann Kyi, Monica Lane, et al.
The New England Journal of Medicine
|
August 27, 2020
Efficacy of Selpercatinib in <i>RET</i>-Altered Thyroid Cancers
Lori J Wirth, Eric Sherman, Bruce Robinson, et al.
Arthritis Care & Research
|
May 21, 2020
Comparison of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria With Two Sets of Earlier Systemic Lupus Erythematosus Classification Criteria
Michelle Petri, Daniel W Goldman, Graciela S Alarcón, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 305) with videos related to
Sort By:
Page
of 31
The New England Journal of Medicine
|
April 30, 2015
Rociletinib in EGFR-mutated non-small-cell lung cancer
Lecia V Sequist, Jean-Charles Soria, Jonathan W Goldman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 18, 2025
Amivantamab in Participants with Advanced Non-small Cell Lung Cancer (NSCLC) and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study
Matthew G Krebs, Byoung Chul Cho, Sandrine Hiret, et al.
Cancer
|
November 11, 2017
Non-small cell lung cancer clinical trials requiring biopsies with biomarker-specific results for enrollment provide unique challenges
Marshall L Spiegel, Jonathan W Goldman, Brian R Wolf, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 13, 2021
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Apar Kishor P Ganti, Billy W Loo, Michael Bassetti, et al.
Cancer Discovery
|
November 17, 2019
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Lawrence Fong, Andrew Hotson, John D Powderly, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 11, 2026
NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026
Apar Kishor P Ganti, Billy W Loo, Shahed Badiyan, et al.
The New England Journal of Medicine
|
March 25, 2026
Setidegrasib in Advanced Non-Small-Cell Lung Cancer and Pancreatic Cancer
Wungki Park, Anup Kasi, Alexander I Spira, et al.
Nature Medicine
|
March 28, 2024
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
Amy R Rappaport, Chrisann Kyi, Monica Lane, et al.
The New England Journal of Medicine
|
August 27, 2020
Efficacy of Selpercatinib in <i>RET</i>-Altered Thyroid Cancers
Lori J Wirth, Eric Sherman, Bruce Robinson, et al.
Arthritis Care & Research
|
May 21, 2020
Comparison of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria With Two Sets of Earlier Systemic Lupus Erythematosus Classification Criteria
Michelle Petri, Daniel W Goldman, Graciela S Alarcón, et al.
Page
of 31